$6.75
-0.20-2.88%
Last update: Nov 11, 5:23 PM
Satellos Bioscience Inc
MSLENASDAQ
Satellos Bioscience fell 40.0% from $11.25 to $6.75, behind the S&P 500's +10.0%. Its worst day was Mar 10 (−18.6%), and its low came Apr 7 at $5.59.
Feb 6, 2026 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Satellos Bioscience closed at its highest level of the year, 15.6% above where the year started.
+5.3% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Satellos Bioscience shares fell 18.6%, while the S&P 500 fell 0.2%.
−18.6%, the year's worst day · S&P 500 −0.2%
Satellos Bioscience closed at its lowest level of the year, 50.3% below where the year started.
−1.1% · S&P 500 0.0%
Satellos Bioscience shares rose 17.5%, while the S&P 500 rose 0.2%.
+17.5% · S&P 500 +0.2%
EPS of $-0.53 was reported on $0.00 revenue.
−2.2% · S&P 500 −1.2%
Satellos Bioscience shares rose 19.4%, while the S&P 500 rose 0.1%.
+19.4%, the year's best day · S&P 500 +0.1%
Satellos Bioscience shares rose 14.7%, while the S&P 500 fell 0.1%.
+14.7% · S&P 500 −0.1%
EPS of $-0.56 missed the $-0.53 estimate on $0.00 revenue.
−2.1% · S&P 500 −0.2%
Where it ended: a close of $6.75 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.59).
Nothing in the past 12 months.
All MSLE dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MSLE and SPY from Benzinga historical bars. Not investment advice.
